Point72 Hong Kong’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Point72 Hong Kong’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-781	Closed	-$59K	–	2580
2022 Q2	$59K	Sell	781 -2,778	-78%	-$123K	﹤0.01%	1335
2022 Q1	$96K	Buy	+3,559	New	+$120K	﹤0.01%	1168
2021 Q2	–	Sell	-591	Closed	-$56K	–	2487
2021 Q1	$56K	Buy	+591	New	+$70.3K	﹤0.01%	1264
2020 Q2	–	Sell	-535	Closed	-$24K	–	1510
2020 Q1	$24K	Buy	+535	New	+$28.4K	0.01%	509
2019 Q3	–	Sell	-29	Closed	-$1K	–	1462
2019 Q2	$1K	Buy	+29	New	+$1.03K	﹤0.01%	1076

Point72 Hong Kong's TPTX Position: Q3 2022 in Review

Point72 Hong Kong sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 781 shares — an estimated $59K sold.

Point72 Hong Kong first reported a position in TPTX in Q2 2019 and held it in 5 quarters. The position peaked at $96K in Q1 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Point72 Hong Kong reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Point72 Hong Kong sold 781 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $59K.
Point72 Hong Kong first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
Point72 Hong Kong's Turning Point Therapeutics, Inc. Common Stock position peaked at $96K in Q1 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.